$AKAN Cashflow Statement | Understand Stock

$AKAN

$1.05 +$0.04 (3.96%) Close

$AKAN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss from continuing operations
Net gain (loss) from discontinued operations
Net loss for the year
Adjustments for non-cash items:
Loss on loss of control of Bophelo Bio, net of cash surrendered
Gain on bargain purchase
Share based payments to social development trust
Gain on loss of control of Canmart, net of cash surrendered and foreign currency translation adjustment
Depreciation and amortization
Interest expenses
Depreciation and amortization from discontinued operations
Change in fair value of biological assets
Change in fair value of financial asset at fair value through profit or loss
Stock-based compensation
Interest expenses and accretion
Fair value of RSU's issued
Interest expenses from discontinued operations
Interest income from Bridge loans
Fair value of RSUs granted and exercised
Trade and other receivables
Gain on settlement on debt
Gain on sale of subsidiary
Write-off of AP, net
Write-off of holdback payable
Write-off of loan receivable
Foreign exchange gain, net
Impairment loss
Change in fair value of financial liabilities at FVTPL

Working capital adjustments (net of amounts acquired/disposed):
Trade and other receivables
Prepayments
Inventory
Trade and other payables
Due to related parties
Cash flows used in operating activities
Cash flows used in operating activities
Cash flows from investing activities:
Acquisition of Holigen, net of cash acquired and holdback
Purchase of financial assets at fair value through profit or loss
Additions to property, plant and equipment
Cash surrendered on sale of RPK
Net cash proceeds from sale of subsidiary
Loan receivable
Loan repayment (receivable)
Cash lent for Bridge loan
Cash surrendered on loss of control of Canmart
Acquisition of First Towers, net of cash acquired and unpaid note consideration
Cash flows used in investing activities

Cash flows from financing activities:
Proceeds from IPO, net of costs
Proceeds from private placement, net of costs
Advances from related parties
Proceeds from issuance of convertible promissory notes
Advances from (to) related parties
Loans received
Loans repaid
Cash flows provided by financing activities

Net increase (decrease) in cash and cash equivalents
Effects of exchange rate changes on cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year

Comments